Cargando…
Sipa1l1 is an early biomarker of liver fibrosis in CCl(4)-treated rats
At present, several procedures are used for staging liver fibrosis. However, these methods may involve clinical complications and/or present diagnostic uncertainty mainly in the early stages of the disease. Thus, this study was designed to unveil new non-invasive biomarkers of liver fibrosis in an i...
Autores principales: | Marfà, Santiago, Morales-Ruiz, Manuel, Oró, Denise, Ribera, Jordi, Fernández-Varo, Guillermo, Jiménez, Wladimiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920198/ https://www.ncbi.nlm.nih.gov/pubmed/27230648 http://dx.doi.org/10.1242/bio.018887 |
Ejemplares similares
-
Cerium oxide nanoparticles improve liver regeneration after acetaminophen-induced liver injury and partial hepatectomy in rats
por: Córdoba-Jover, Bernat, et al.
Publicado: (2019) -
Cerium Oxide Nanoparticles Protect against Oxidant Injury and Interfere with Oxidative Mediated Kinase Signaling in Human-Derived Hepatocytes
por: Carvajal, Silvia, et al.
Publicado: (2019) -
Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease
por: Carvajal, Silvia, et al.
Publicado: (2019) -
Lack of a 5.9 kDa Peptide C-Terminal Fragment of Fibrinogen α Chain Precedes Fibrosis Progression in Patients with Liver Disease
por: Marfà, Santiago, et al.
Publicado: (2014) -
Fibrinogen α-Chain as a Serum Marker of Liver Disease
por: Marfà, Santiago, et al.
Publicado: (2016)